focus trial semaglutide evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of in early-stage symptomatic Alzheimer's disease | Alzheimer's Research & Therapy Long-term weight loss effects of

Here for You: Do you test your products and provide COAs

tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors

Recent large-scale observational and trial-based studies have highlighted that incretin-based therapies, including dual Glucose-dependent insulinotropic polypeptide / glucagon-like peptide-1 receptor agonists (GIP/GLP-1 receptor agonists) such as tirzepatide, may confer benefits beyond weight loss, including reductions in all-cause mortality, major adverse cardiovascular events, and renal outcomes [25]

(1998): Reversal of age-related muscle wasting in preclinical models

Bahamonde C, Conde C, Agera E et al (2014) Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: relationship to oxidative stress